NEW YORK (Reuters Health) - Contrary to preliminary findings, the results of a phase III study failed to show that dextromethorphan significantly enhanced the analgesic effects of morphine in ...
Leqvio (inclisiran) may cause injection site reactions, including bruising, pain, discoloration, itchiness, and a burning or prickling sensation at the injection site. In addition to injection site ...
The FDA approved combination dextromethorphan and bupropion extended-release tablets (Auvelity) for adults with major depressive disorder (MDD), Axsome Therapeutics announced on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback